By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Researchers from the Dana-Farber Cancer Institute have come up with a risk score based on the expression of almost two-dozen DNA repair-related genes that they say can help predict ovarian cancer outcomes following platinum-based chemotherapy.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.